These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 39026851)

  • 1. Heli-SMACC: Helicase-targeting SMAll Molecule Compound Collection.
    Martin HJ; Hossain MA; Wellnitz J; Kelestemur E; Hochuli JE; Parveen S; Arrowsmith C; Willson TM; Muratov E; Tropsha A
    bioRxiv; 2024 Jul; ():. PubMed ID: 39026851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule antiviral compound collection (SMACC): A comprehensive, highly curated database to support the discovery of broad-spectrum antiviral drug molecules.
    Martin HJ; Melo-Filho CC; Korn D; Eastman RT; Rai G; Simeonov A; Zakharov AV; Muratov E; Tropsha A
    Antiviral Res; 2023 Sep; 217():105620. PubMed ID: 37169224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small Molecule Antiviral Compound Collection (SMACC): a database to support the discovery of broad-spectrum antiviral drug molecules.
    Martin HJ; Melo-Filho CC; Korn D; Eastman RT; Rai G; Simeonov A; Zakharov AV; Muratov E; Tropsha A
    bioRxiv; 2022 Jul; ():. PubMed ID: 35860225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity.
    Mohammad TSH; Gupta Y; Reidl CT; Nicolaescu V; Gula H; Durvasula R; Kempaiah P; Becker DP
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting SARS-CoV-2 nsp13 Helicase and Assessment of Druggability Pockets: Identification of Two Potent Inhibitors by a Multi-Site In Silico Drug Repurposing Approach.
    Romeo I; Ambrosio FA; Costa G; Corona A; Alkhatib M; Salpini R; Lemme S; Vergni D; Svicher V; Santoro MM; Tramontano E; Ceccherini-Silberstein F; Artese A; Alcaro S
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of compounds targeting SARS-CoV-2 helicase.
    Halma MTJ; Wever MJA; Abeln S; Roche D; Wuite GJL
    Front Chem; 2022; 10():1062352. PubMed ID: 36561139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance.
    Grimes SL; Choi YJ; Banerjee A; Small G; Anderson-Daniels J; Gribble J; Pruijssers AJ; Agostini ML; Abu-Shmais A; Lu X; Darst SA; Campbell E; Denison MR
    mBio; 2023 Aug; 14(4):e0106023. PubMed ID: 37338298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp13 helicase.
    Zeng J; Weissmann F; Bertolin AP; Posse V; Canal B; Ulferts R; Wu M; Harvey R; Hussain S; Milligan JC; Roustan C; Borg A; McCoy L; Drury LS; Kjaer S; McCauley J; Howell M; Beale R; Diffley JFX
    Biochem J; 2021 Jul; 478(13):2405-2423. PubMed ID: 34198322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronavirus helicases: attractive and unique targets of antiviral drug-development and therapeutic patents.
    Spratt AN; Gallazzi F; Quinn TP; Lorson CL; Sönnerborg A; Singh K
    Expert Opin Ther Pat; 2021 Apr; 31(4):339-350. PubMed ID: 33593200
    [No Abstract]   [Full Text] [Related]  

  • 10. The PKA-CREB1 axis regulates coronavirus proliferation by viral helicase nsp13 association.
    Zheng T; Shen B; Bai Y; Li E; Zhang X; Hu Y; Gao T; Dong Q; Zhu L; Jin R; Shi H; Liu H; Gao Y; Liu X; Cao C
    J Virol; 2024 Apr; 98(4):e0156523. PubMed ID: 38445884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling.
    Pitsillou E; Liang J; Hung A; Karagiannis TC
    J Mol Graph Model; 2022 Jul; 114():108193. PubMed ID: 35462185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe acute respiratory syndrome coronavirus replication inhibitor that interferes with the nucleic acid unwinding of the viral helicase.
    Adedeji AO; Singh K; Calcaterra NE; DeDiego ML; Enjuanes L; Weiss S; Sarafianos SG
    Antimicrob Agents Chemother; 2012 Sep; 56(9):4718-28. PubMed ID: 22733076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 nsp13 Restricts Episomal DNA Transcription without Affecting Chromosomal DNA.
    Li A; Zhang B; Zhao K; Yin Z; Teng Y; Zhang L; Xu Z; Liang K; Cheng X; Xia Y
    J Virol; 2023 Jul; 97(7):e0051223. PubMed ID: 37347173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should We Try SARS-CoV-2 Helicase Inhibitors for COVID-19 Therapy?
    Habtemariam S; Nabavi SF; Banach M; Berindan-Neagoe I; Sarkar K; Sil PC; Nabavi SM
    Arch Med Res; 2020 Oct; 51(7):733-735. PubMed ID: 32536457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Repurposed Drug Interferes with Nucleic Acid to Inhibit the Dual Activities of Coronavirus Nsp13.
    Soper N; Yardumian I; Chen E; Yang C; Ciervo S; Oom AL; Desvignes L; Mulligan MJ; Zhang Y; Lupoli TJ
    ACS Chem Biol; 2024 Jul; 19(7):1593-1603. PubMed ID: 38980755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic Characterization of SARS-CoV-2 nsp13 ATPase Activity and Discovery of Small-Molecule Inhibitors.
    Yazdi AK; Pakarian P; Perveen S; Hajian T; Santhakumar V; Bolotokova A; Li F; Vedadi M
    ACS Infect Dis; 2022 Aug; 8(8):1533-1542. PubMed ID: 35822715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Virtual Screening Identifies Multiple Stable Binding Sites at the RecA Domains of SARS-CoV-2 Helicase Enzyme.
    Ahmad S; Waheed Y; Ismail S; Bhatti S; Abbasi SW; Muhammad K
    Molecules; 2021 Mar; 26(5):. PubMed ID: 33800013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High throughput screening for SARS-CoV-2 helicase inhibitors.
    Otsuka Y; Kim E; Krueger A; Shumate J; Wang C; Bdiri B; Ullah S; Park H; Scampavia L; Bannister TD; Chung D; Spicer TP
    SLAS Discov; 2024 Sep; 29(6):100180. PubMed ID: 39173831
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Gurung AB
    Gene Rep; 2020 Dec; 21():100860. PubMed ID: 32875166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity and inhibition of the SARS-CoV-2 Omicron nsp13 R392C variant using RNA duplex unwinding assays.
    Inniss NL; Rzhetskaya M; Ling-Hu T; Lorenzo-Redondo R; Bachta KE; Satchell KJF; Hultquist JF
    SLAS Discov; 2024 Apr; 29(3):100145. PubMed ID: 38301954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.